Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Saved in:
Bibliographic Details
Title: Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
Authors: Barbastefano, Juan1, Garcia, Jorge A.2,3, Elson, Paul2, Wood, Laura S.2, Lane, Brian R.3, Dreicer, Robert2,3, Campbell, Steven C.3, Rini, Brian I.2,3 rinib2@ccf.org
Source: BJU International. Nov2010, Vol. 106 Issue 9, p1266-1269. 4p. 2 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:14644096
DOI:10.1111/j.1464-410X.2010.09323.x